FRANKLIN, Mass., May 8 /PRNewswire-FirstCall/ -- Sontra Medical
Corporation (OTC Bulletin Board: SONT.OB) announced today that its common
stock is now quoted on the OTC Bulletin Board under the symbol "SONT.OB".
The Company's common stock was previously quoted on the "Pink Sheets" under
the symbol "SONT.PK".
About Sontra Medical Corporation (http://www.sontra.com)
Sontra Medical Corporation, a technology leader in transdermal science,
is developing a non-invasive, continuous transdermal glucose monitor
("CTGM") for use in the Diabetes and Intensive Care Markets. In addition,
the Company owns the FDA approved SonoPrep(R) ultrasound-mediated skin
permeation technology, presently used with topical lidocaine to achieve
rapid (within five minutes) skin anesthesia. The Company is using its
technical competencies in transdermal drug formulation, delivery systems
and biosensors to develop a new paradigm in transdermal drug delivery and
diagnosis.
SonoPrep is a registered trademark of Sontra Medical Corporation. All
other company, product or service names mentioned herein are the trademarks
or registered trademarks of their respective owners.
Investor Relations Contact:
Harry G. Mitchell, Interim CEO
508-530-0311
hmitchell@sontra.com
SOURCE Sontra Medical Corporation
 back to top
Related links:
http://www.sontra.com/
CONTACT:
Investor Relations: Harry G. Mitchell,
Interim CEO of Sontra Medical Corporation, +1-508-530-0311,
hmitchell@sontra.com
|
